ENVISTA HOLDINGS CORPORATION financials

NVST CIK 0001757073

Source: EDGAR filings · Built 2026-06-02T03:42:09Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 230.40M 302.70M 217.50M 107.00M 306.90M 236.20M
EBITDA 332.10M -915.10M 167.10M 457.00M 424.00M 165.20M
Working Capital 1.17B 909.60M 962.90M 187.90M 627.60M -94.10M
Net Debt 386.00M 594.60M 828.90M 1.43B 818.70M 1.98B
Gross Margin 54.67% 54.68% 56.13% 57.41% 56.86% 54.68%
Operating Margin 7.95% -41.35% 1.23% 12.42% 12.20% 2.25%
Net Margin 1.73% -44.56% -3.90% 9.46% 13.57% 1.73%
Return on Equity (ROE) 1.51% -38.12% -2.40% 5.78% 8.39% 0.90%
Return on Assets (ROA) 0.83% -20.91% -1.52% 3.69% 5.18% 0.48%
Current Ratio 2.38× 2.04× 2.23× 1.15× 1.52× 0.94×
Debt-to-Equity 0.51× 0.57× 0.42× 0.48× 0.47× 0.77×
Effective Tax Rate 73.48% -3.13% -82.51% 16.17% -3.54% 312.50%
Cash Conversion Ratio 5.87× -0.30× -2.75× 0.75× 1.06× 8.53×
Accruals Ratio -0.04× -0.27× -0.06× 0.01× -0.00× -0.04×
SBC % of Revenue 1.38% 1.41% 1.20% 1.19% 1.12% 1.17%
CapEx Coverage 6.09× 9.96× 4.74× 2.41× 6.61× 5.95×
Free Cash Flow Per Share $1.36 $1.76 $1.30 $0.60 $1.73 $1.44

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 77.54× 24.58× 23.47× 168.65×
P/FCF 15.94× 10.97× 18.46× 55.88× 26.08× 23.43×
FCF Yield 6.27% 9.11% 5.42% 1.79% 3.83% 4.27%
EV / EBITDA 11.87× 29.65× 15.16× 19.10× 44.65×
P/S 1.31× 1.32× 1.61× 2.14× 2.90× 2.80×
P/B 1.14× 1.13× 0.99× 1.31× 1.79× 1.45×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.72B 2.51B 2.57B 2.57B 2.51B 1.93B
Revenues 2.57B 2.57B 2.51B 1.93B
Cost of Goods and Services Sold 1.23B 1.14B 1.13B 1.09B 1.08B 874.30M
Gross Profit 1.49B 1.37B 1.44B 1.47B 1.43B 1.05B
Research and Development Expense 114.00M 99.10M 93.80M 100.10M 100.50M 86.70M
Selling, General and Administrative Expense 1.16B 1.16B 1.06B 1.06B 1.02B 924.60M
Operating Expenses 2.27B 2.18B 2.13B
Operating Income (Loss) 216.10M -1.04B 31.50M 319.20M 306.20M 43.50M
Income Tax Expense (Benefit) 130.20M 33.90M 45.30M 45.90M -9.00M -62.50M
Net Income (Loss) Attributable to Parent 47.00M -1.12B -100.20M 243.10M 340.50M 33.30M
Earnings Per Share, Basic $0.28 $-6.50 $-0.60 $1.49 $2.11 $0.21
Weighted Average Number of Shares Outstanding, Basic 168.00M 172.20M 166.90M 162.90M 161.20M 159.60M
Earnings Per Share, Diluted $0.28 $-6.50 $-0.60 $1.37 $1.92 $0.20
Weighted Average Number of Shares Outstanding, Diluted 169.20M 172.20M 166.90M 177.60M 177.60M 164.10M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.21B 1.07B 940.00M 606.90M 1.07B 888.90M
Assets, Current 2.03B 1.79B 1.74B 1.42B 1.84B 1.59B
Assets 5.68B 5.35B 6.61B 6.59B 6.57B 6.88B
Long-term Debt 1.45B 1.39B 1.51B 1.38B 1.32B 1.79B
Liabilities, Current 852.60M 878.70M 780.80M 1.24B 1.21B 1.68B
Long-term Debt, Excluding Current Maturities 1.45B 1.28B 1.40B 870.70M 883.40M 907.70M
Stockholders' Equity Attributable to Parent 3.11B 2.93B 4.17B 4.21B 4.06B 3.72B
Common Stock, Shares, Outstanding 163.80M 172.20M 171.50M 163.20M 161.60M 160.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 275.70M 336.50M 275.70M 182.70M 361.60M 283.90M
Payments to Acquire Property, Plant, and Equipment 45.30M 33.80M 58.20M 75.70M 54.70M 47.70M
Net Cash Provided by (Used in) Investing Activities -51.10M -54.60M -62.40M -657.30M 262.70M -69.10M
Net Cash Provided by (Used in) Financing Activities -170.90M -103.70M 118.90M 12.50M -465.60M 492.50M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NVST CIK 0001757073), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IAC

IAC Inc.

RPRX

Royalty Pharma plc

BBNX

BETA BIONICS, INC.